{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T20:55:28Z","timestamp":1785185728238,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.vhri.2023.03.002","type":"journal-article","created":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T15:08:47Z","timestamp":1680966527000},"page":"66-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Healthcare Resource Utilization in Controlled Versus Uncontrolled Adults Living With Type 1 Diabetes in the South African Public Healthcare Sector"],"prefix":"10.1016","volume":"36","author":[{"given":"Sindeep","family":"Bhana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebrahim","family":"Variava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tinashe V.","family":"Mhazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janetta C.","family":"de Beer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poobalan","family":"Naidoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somasundram","family":"Pillay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Carrihill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiolan","family":"Naidoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luzaan","family":"van Wyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Pauly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vhri.2023.03.002_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s41043-022-00281-2","article-title":"Assessment of prevalence and risk factors of diabetes and pre-diabetes in South Africa","volume":"41","author":"Grundlingh","year":"2022","journal-title":"J\u00a0Health Popul Nutr"},{"issue":"3","key":"10.1016\/j.vhri.2023.03.002_bib4","first-page":"130","article-title":"The epidemiology and pathogenesis of type 1 diabetes mellitus in Africa","volume":"16","author":"Padoa","year":"2011","journal-title":"JEMDSA"},{"issue":"14","key":"10.1016\/j.vhri.2023.03.002_bib5","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1056\/NEJMsr1405012","article-title":"Health and health care in South Africa--20 years after Mandela","volume":"371","author":"Mayosi","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.vhri.2023.03.002_bib6","first-page":"635","article-title":"A\u00a0total cost perspective of type 1 and 2 diabetes mellitus in two South African medical schemes servicing the public healthcare sector","volume":"111","author":"Opperman","year":"2021","journal-title":"S\u00a0Afr Med J"},{"issue":"2","key":"10.1016\/j.vhri.2023.03.002_bib7","first-page":"46","article-title":"Characteristics of children presenting with newly diagnosed type 1 diabetes","volume":"7","author":"Reddy","year":"2013","journal-title":"S\u00a0Afr J Chem"},{"issue":"25","key":"10.1016\/j.vhri.2023.03.002_bib8","article-title":"Management of adult patients with type 1 diabetes mellitus in Africa: a post-hoc cohort analysis of 12 African countries participating in the International Diabetes Management Practices Study (Wave 7)","volume":"99","author":"Mbanya","year":"2020","journal-title":"Medicines (Baltimore)"},{"issue":"2","key":"10.1016\/j.vhri.2023.03.002_bib9","first-page":"36","article-title":"Trends in glycaemic control and morbidity over 10 years in patients with type 1 diabetes mellitus at Inkosi Albert Luthuli Central Hospital","volume":"25","author":"Hoosen","year":"2021","journal-title":"JEMDSA"},{"issue":"suppl 1","key":"10.1016\/j.vhri.2023.03.002_bib10","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1185\/030079904X1980","article-title":"The CORE Diabetes Model: projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making","volume":"20","author":"Palmer","year":"2004","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"10.1016\/j.vhri.2023.03.002_bib11","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jval.2014.07.007","article-title":"Validation of the IMS CORE diabetes model","volume":"17","author":"McEwan","year":"2014","journal-title":"Value Health"},{"issue":"1suppl 1","key":"10.1016\/j.vhri.2023.03.002_bib13","first-page":"S1","article-title":"SEMDSA 2017 Guidelines for the Management of Type 2 Diabetes Mellitus","volume":"22","year":"2017","journal-title":"J\u00a0Endocrinol Metab Diabetes S Afr"},{"issue":"1","key":"10.1016\/j.vhri.2023.03.002_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/16089677.2017.1385966","article-title":"Incidence of hypoglycaemia among insulin-treated patients with type 1 or type 2 diabetes mellitus: South African cohort of International Operations Hypoglycaemia Assessment Tool (IO HAT) study","volume":"23","author":"Omar","year":"2018","journal-title":"J\u00a0Endocrinol Metab Diabetes S Afr"},{"issue":"6","key":"10.1016\/j.vhri.2023.03.002_bib15","first-page":"420","article-title":"Economic impact of severe and non-severe hypoglycemia in patients with type 1 and type 2 diabetes in the United States","volume":"18","author":"Foos","year":"2015","journal-title":"J\u00a0Med Econ"},{"issue":"2","key":"10.1016\/j.vhri.2023.03.002_bib19","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1016\/S2214-109X(18)30450-9","article-title":"Implications of scaling up cardiovascular disease treatment in South Africa: a microsimulation and cost-effectiveness analysis","volume":"7","author":"Basu","year":"2019","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vhri.2023.03.002_bib20","author":"De Waal"},{"issue":"4","key":"10.1016\/j.vhri.2023.03.002_bib21","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/jep.13287","article-title":"Estimating the costs and benefits of stroke rehabilitation in South Africa","volume":"26","author":"Louw","year":"2020","journal-title":"J\u00a0Eval Clin Pract"},{"issue":"3","key":"10.1016\/j.vhri.2023.03.002_bib22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s13410-013-0173-8","article-title":"Comparative hospitalization cost and length of stay between patients with and without diabetes in a large tertiary hospital in Johannesburg, South Africa","volume":"34","author":"Ncube-Zulu","year":"2013","journal-title":"Int J Diabetes Dev Ctries"},{"issue":"4","key":"10.1016\/j.vhri.2023.03.002_bib23","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s41669-019-0124-5","article-title":"A\u00a0cost analysis of haemodialysis and peritoneal dialysis for the management of end-stage renal failure at an Academic Hospital in Pretoria, South Africa","volume":"3","author":"Makhele","year":"2019","journal-title":"Pharmacoecon Open"},{"issue":"4","key":"10.1016\/j.vhri.2023.03.002_bib24","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/20786204.2013.10874378","article-title":"Is screening for microalbuminuria in patients with type 2 diabetes feasible in the Cape Town public sector primary care context? A cost and consequence study","volume":"55","author":"Ibrahim","year":"2013","journal-title":"S\u00a0Afr Fam Pract"},{"issue":"2","key":"10.1016\/j.vhri.2023.03.002_bib25","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.diabres.2013.05.006","article-title":"Preventing diabetes blindness: cost effectiveness of a screening programme using digital non-mydriatic fundus photography for diabetic retinopathy in a primary health care setting in South Africa","volume":"101","author":"Khan","year":"2013","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"10.1016\/j.vhri.2023.03.002_bib26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/16089677.2020.1782007","article-title":"Counting the cost of preventable diabetes-related lower limb amputations at a single district hospital in KwaZulu-Natal: what does this mean, what can be done?","volume":"25","author":"Thompson","year":"2020","journal-title":"J\u00a0Endocrinol Metab Diabetes S Afr"},{"key":"10.1016\/j.vhri.2023.03.002_bib27","unstructured":"Vote 18 health budget summary. Republic of South Africa National Treasury. https:\/\/www.treasury.gov.za\/documents\/national%20budget\/2022\/ene\/Vote%2018%20Health.pdf. Accessed January 12, 2023."},{"issue":"11","key":"10.1016\/j.vhri.2023.03.002_bib28","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.2337\/dci21-0043","article-title":"The management of Type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"44","author":"Holt","year":"2021","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.vhri.2023.03.002_bib29","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jdiacomp.2014.04.003","article-title":"Reduced risk of hypoglycemia with once-daily glargine versus twice-daily NPH and number needed to harm with NPH to demonstrate the risk of one additional hypoglycemic event in type 2 diabetes: evidence from a long-term controlled trial","volume":"28","author":"Rosenstock","year":"2014","journal-title":"J\u00a0Diabetes Complications"},{"issue":"4","key":"10.1016\/j.vhri.2023.03.002_bib30","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1515\/JPEM.2002.15.4.369","article-title":"Pediatric Study Group of Insulin Glargine. Comparative trial between insulin glargine and NPH Insulin in children and adolescents with type 1 diabetes mellitus","volume":"15","author":"Schober","year":"2002","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.vhri.2023.03.002_bib31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4158\/EP.11.1.11","article-title":"Optimized Basal-bolus insulin regimens in type 1 diabetes: insulin glulisine versus regular human insulin in combination with Basal insulin glargine","volume":"11","author":"Garg","year":"2005","journal-title":"Endocr Pract"},{"key":"10.1016\/j.vhri.2023.03.002_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1478-7547-4-1","article-title":"The association between diabetes related medical costs and glycemic control: a retrospective analysis","volume":"4","author":"Oglesby","year":"2006","journal-title":"Cost Eff Resour Alloc"},{"issue":"2","key":"10.1016\/j.vhri.2023.03.002_bib33","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s13300-022-01212-4","article-title":"The association between HbA1c and 1-year diabetes-related medical costs: a retrospective claims database analysis","volume":"13","author":"Boye","year":"2022","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.vhri.2023.03.002_bib34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2147\/CEOR.S41846","article-title":"Glycemic control and diabetes-related health care costs in type 2 diabetes; retrospective analysis based on clinical and administrative databases","volume":"5","author":"Degli Esposti","year":"2013","journal-title":"Clinicoecon Outcomes Res"},{"issue":"11","key":"10.1016\/j.vhri.2023.03.002_bib35","first-page":"1399","article-title":"Healthcare resource utilization and cost among patients with type 1 diabetes in the United States","volume":"26","author":"Simeone","year":"2020","journal-title":"J\u00a0Manag Care Spec Pharm"},{"issue":"3","key":"10.1016\/j.vhri.2023.03.002_bib36","first-page":"311","article-title":"Estimation of annual health care costs for adults with Type 1 diabetes in the United States","volume":"26","author":"Joish","year":"2020","journal-title":"J\u00a0Manag Care Spec Pharm"},{"issue":"2","key":"10.1016\/j.vhri.2023.03.002_bib37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/dia.2019.0398","article-title":"Estimated lifetime economic burden of Type 1 diabetes","volume":"22","author":"Sussman","year":"2020","journal-title":"Diabetes Technol Ther"},{"issue":"11","key":"10.1016\/j.vhri.2023.03.002_bib38","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/dme.13062","article-title":"Estimating the impact of better management of glycaemic control in adults with Type 1 and Type 2 diabetes on the number of clinical complications and the associated financial benefit","volume":"33","author":"Baxter","year":"2016","journal-title":"Diabet Med"},{"issue":"5","key":"10.1016\/j.vhri.2023.03.002_bib39","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/dme.13590","article-title":"Assessing the economic value of maintained improvements in type 1 diabetes management, in terms of HbA1c, weight and hypoglycaemic event incidence","volume":"35","author":"McEwan","year":"2018","journal-title":"Diabet Med"},{"issue":"4","key":"10.1016\/j.vhri.2023.03.002_bib40","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1172\/JCI97696","article-title":"Hypoglycemia unawareness in type 1 diabetes suppresses brain responses to hypoglycemia","volume":"128","author":"Hwang","year":"2018","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.vhri.2023.03.002_bib41","doi-asserted-by":"crossref","first-page":"b4909","DOI":"10.1136\/bmj.b4909","article-title":"The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the Accord study","volume":"340","author":"Bonds","year":"2010","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.vhri.2023.03.002_bib42","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2018-000593","article-title":"Impact of a structured patient support program on adherence and persistence in basal insulin therapy for type 2 diabetes","volume":"6","author":"Zhou","year":"2018","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.vhri.2023.03.002_bib43","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.diabres.2017.02.001","article-title":"Effects of a lifestyle education program on glycemic control among patients with diabetes at Kigali University Hospital, Rwanda: a randomized controlled trial","volume":"126","author":"Amendezo","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.vhri.2023.03.002_bib44","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13098-018-0397-3","article-title":"Short-acting insulin analogues versus regular human insulin on postprandial glucose and hypoglycemia in type 1 diabetes mellitus: a systematic review and meta-analysis","volume":"11","author":"Melo","year":"2019","journal-title":"Diabetol Metab Syndr"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109923000304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109923000304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T20:23:30Z","timestamp":1708633410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109923000304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":38,"alternative-id":["S2212109923000304"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2023.03.002","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Healthcare Resource Utilization in Controlled Versus Uncontrolled Adults Living With Type 1 Diabetes in the South African Public Healthcare Sector","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2023.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society for Health Economics and Outcomes Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}